J.P. Morgan Exchange-Traded Fund Trust (JDOC)
管理公司 · NASD · 系列 S000080528 · 在 SEC EDGAR 上查看 ↗
$64.56
截至 2026年8月19日
▲ +1.71 (+2.72%)
1日变动
$50.34 – $64.56
52周范围
- 净资产
- $11.1M
- 持仓
- 66
- 截至
- 2026年4月30日 陈旧
- 前十大持仓权重
- 46.55%
- 有效持仓数量
- 31.7
- 持仓高于 1%
- 32
本页内容
JDOC 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
业绩 截至 2026年3月10日
| 期间 | 价格回报 | 总回报 |
|---|---|---|
| 1M | ▼ -2.27% | — |
| 3M | ▼ -1.14% | — |
| 6M | ▲ +10.45% | — |
| 年初至今 | ▼ -1.31% | — |
| 1Y | ▲ +6.53% | — |
| 3Y | — | — |
| 5Y | — | — |
| 最大 自 2024年2月27日 起 | ▼ -1.56% | — |
- 1年波动率
- 16.71%
- 3年波动率
- —
- 3年最大回撤
- —
- 3年Beta值
- —
- 1年夏普比率*
- 0.47
在收集完该基金的股息历史后，将显示总回报率——仅显示价格回报率会产生误导性的重复。回报率未与指数进行基准比较。 * 夏普比率按0%无风险利率计算。
基金流向（SEC报告）
- 上个月（四月 2026）
- +$1.4M
- 截至四月 2026的季度
- +$2.8M
- 过去12个月
- +$2.8M
五月 2025 – 四月 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
完整构成 66 持仓
| 名称 | CUSIP | 价值 | % | 余额 | 类别 | 国家 |
|---|---|---|---|---|---|---|
| Eli Lilly & Co. | 532457108 | $758K | 6.81 | 811 | EC | US |
| AbbVie, Inc. | 00287Y109 | $732K | 6.58 | 3464 | EC | US |
| Johnson & Johnson | 478160104 | $690K | 6.20 | 3001 | EC | US |
| UnitedHealth Group, Inc. | 91324P102 | $649K | 5.83 | 1751 | EC | US |
| AstraZeneca plc | — | $508K | 4.57 | 2677 | EC | GB |
| Merck & Co., Inc. | 58933Y105 | $468K | 4.21 | 4289 | EC | US |
| Bristol-Myers Squibb Co. | 110122108 | $389K | 3.50 | 6427 | EC | US |
| Thermo Fisher Scientific, Inc. | 883556102 | $354K | 3.19 | 740 | EC | US |
| Intuitive Surgical, Inc. | 46120E602 | $329K | 2.96 | 719 | EC | US |
| CVS Health Corp. | 126650100 | $301K | 2.71 | 3618 | EC | US |
| Novo Nordisk A/S | — | $295K | 2.65 | 6943 | EC | DK |
| Roche Holding AG | — | $295K | 2.65 | 723 | EC | CH |
| Hoya Corp. | — | $261K | 2.35 | 1400 | EC | JP |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $243K | 2.19 | 344 | EC | US |
| Boston Scientific Corp. | 101137107 | $227K | 2.04 | 3946 | EC | US |
| UCB SA | — | $219K | 1.97 | 803 | EC | BE |
| Vertex Pharmaceuticals, Inc. | 92532F100 | $218K | 1.96 | 510 | EC | US |
| Danaher Corp. | 235851102 | $212K | 1.90 | 1184 | EC | US |
| Edwards Lifesciences Corp. | 28176E108 | $203K | 1.83 | 2435 | EC | US |
| McKesson Corp. | 58155Q103 | $198K | 1.78 | 243 | EC | US |
| Stryker Corp. | 863667101 | $177K | 1.59 | 562 | EC | US |
| Argenx SE | — | $171K | 1.54 | 218 | EC | NL |
| Teva Pharmaceutical Industries Ltd. | — | $157K | 1.41 | 4466 | EC | IL |
| Cardinal Health, Inc. | 14149Y108 | $154K | 1.38 | 796 | EC | US |
| Centene Corp. | 15135B101 | $147K | 1.32 | 2739 | EC | US |
| Biogen, Inc. | 09062X103 | $145K | 1.30 | 764 | EC | US |
| Zoetis, Inc. | 98978V103 | $131K | 1.17 | 1136 | EC | US |
| United Therapeutics Corp. | 91307C102 | $129K | 1.16 | 226 | EC | US |
| Lonza Group AG | — | $123K | 1.11 | 200 | EC | CH |
| Novartis AG | — | $116K | 1.04 | 783 | EC | CH |
| Fresenius SE & Co. KGaA | — | $115K | 1.04 | 2383 | EC | DE |
| IQVIA Holdings, Inc. | 46266C105 | $115K | 1.03 | 726 | EC | US |
| Sartorius AG | — | $102K | 0.91 | 398 | EC | DE |
| Spyre Therapeutics, Inc. | 00773J202 | $99K | 0.89 | 1327 | EC | US |
| Apogee Therapeutics, Inc. | 03770N101 | $95K | 0.86 | 1152 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $94K | 0.84 | 1257 | EC | US |
| Argenx SE | — | $91K | 0.82 | 116 | EC | NL |
| CG oncology, Inc. | 156944100 | $87K | 0.78 | 1304 | EC | US |
| Ascendis Pharma A/S | — | $79K | 0.71 | 343 | EC | DK |
| Align Technology, Inc. | 016255101 | $77K | 0.69 | 437 | EC | US |
| Immunome, Inc. | 45257U108 | $77K | 0.69 | 3351 | EC | US |
| Dyne Therapeutics, Inc. | 26818M108 | $75K | 0.67 | 4266 | EC | US |
| JPMorgan Securities Lending Money Market Fund | 46645V642 | $71K | 0.64 | 71313 | STIV | US |
| Dexcom, Inc. | 252131107 | $71K | 0.64 | 1196 | EC | US |
| Neurocrine Biosciences, Inc. | 64125C109 | $70K | 0.63 | 533 | EC | US |
| Genmab A/S | — | $70K | 0.63 | 265 | EC | DK |
| Daiichi Sankyo Co. Ltd. | — | $68K | 0.61 | 4200 | EC | JP |
| Convatec Group plc | — | $67K | 0.61 | 23481 | EC | GB |
| Cigna Group (The) | 125523100 | $67K | 0.60 | 231 | EC | US |
| Medtronic plc | — | $65K | 0.59 | 808 | EC | IE |
页 1
/ 2
← 上一页
下一页 →
行业细分
Healthcare
74.1%
其他/未映射
25.9%
机构持有人 (13F) 6 家申报者
在其季度SEC表格13F中报告持有该ETF的机构。仅限多头头寸；单个申报者可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
| 机构 | 价值 | % 已追踪的13F | 股份 | 类型 | 截至 |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | $5353127 | 84.53% | 88196 | 股份 | 2026年6月30日 |
| CITADEL ADVISORS LLC | $449318 | 7.10% | 7460 | 股份 | 2026年6月30日 |
| Krilogy Financial LLC | $266640 | 4.21% | 4427 | 股份 | 2026年6月30日 |
| Sanctuary Advisors, LLC | $250087 | 3.95% | 4152 | 股份 | 2026年6月30日 |
| ROYAL BANK OF CANADA | $7000 | 0.11% | 120 | 股份 | 2026年6月30日 |
| WELLS FARGO & COMPANY/MN | $6384 | 0.10% | 106 | 股份 | 2026年6月30日 |
同类基金
来自该发行方的更多信息
| 基金 | 资产管理规模 |
|---|---|
| JPST J.P. Morgan Exchange-Traded F... | $38.4B |
| BBJP J.P. Morgan Exchange-Traded F... | $16.6B |
| JCPB J.P. Morgan Exchange-Traded F... | $12.4B |
| BBCA J.P. Morgan Exchange-Traded F... | $10.7B |
| JIRE J.P. Morgan Exchange-Traded F... | $10.6B |
| JPIE J.P. Morgan Exchange-Traded F... | $9.1B |
| BBEU J.P. Morgan Exchange-Traded F... | $9.0B |
| JBND J.P. Morgan Exchange-Traded F... | $8.1B |
| BBUS J.P. Morgan Exchange-Traded F... | $7.8B |
| JMUB J.P. Morgan Exchange-Traded F... | $7.8B |
规模相似
| 基金 | 资产管理规模 |
|---|---|
| RDOG ALPS ETF Trust | $11.2M |
| JDIV J.P. Morgan Exchange-Traded F... | $11.2M |
| EMES Harbor ETF Trust | $11.2M |
| FEAT Tidal Trust II | $11.3M |
| QQQG Pacer Funds Trust | $11.3M |
| PEX ProShares Trust | $11.1M |
| TYO Direxion Shares ETF Trust | $11.1M |
| MAPP Harbor ETF Trust | $10.9M |
| REK ProShares Trust | $10.9M |
| CPII AMERICAN BEACON SELECT FUNDS | $10.7M |